ARMC
EPRS

American Research & Management Company’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

American Research & Management Company’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25
Closed – – 406
2015
Q1 		$0 Hold
25
– – ﹤0.01% 386
2014
Q4 		$0 Hold
25
– – ﹤0.01% 390
2014
Q3 		$0 Buy
+25
New +$216 ﹤0.01% 390

Other funds holding EPRS

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

American Research & Management Company's EPRS Position: Q2 2015 in Review

American Research & Management Company sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q2 2015, closing a stake of 25 shares.

American Research & Management Company first reported a position in EPRS in Q3 2014 and held it in 3 quarters. The position peaked at $0 in Q1 2015. 41 funds tracked by Wall St. Rank hold EPRS as of Q2 2015.

  • American Research & Management Company reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q2 2015 after selling out during the quarter.
  • American Research & Management Company sold 25 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q2 2015.
  • American Research & Management Company first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 3 quarters.
  • American Research & Management Company's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $0 in Q1 2015.
  • 41 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q2 2015.

Based on American Research & Management Company's 13F filing for Q2 2015, filed 16 Jul 2015.